Zdrowie i gospodarka · 11/08/2023
FDA Clears ANJESO Meloxicam Solution for Approval
The FDA has determined that ANJESO (meloxicam) solution, 30 mg/mL, was not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of abbreviated new drug applications (ANDAs) for this medication.
Source: Federal Register — Food and Drug AdministrationOpen original release →